Drug Class: Selective Serotonin Reuptake Inhibitor (SSRI) | Form: Oral Controlled-Release Tablet | Prescription Status: Prescription Only (Rx) — DRAP Registered
What is Paraxyl CR 37.5mg Tablet?
Paraxyl CR 37.5mg contains Paroxetine Hydrochloride — one of the most extensively studied and potent selective serotonin reuptake inhibitors (SSRIs) available — in a controlled-release formulation that delivers Paroxetine gradually throughout the day. Unlike immediate-release Paroxetine tablets that release the full dose at once — causing peak blood level spikes associated with nausea and other early side effects — the controlled-release formulation of Paraxyl CR maintains smoother, more stable Paroxetine blood levels over an extended period. This significantly improves tolerability — particularly the nausea that is the most common reason patients stop taking Paroxetine in the early weeks. Paraxyl CR 37.5mg is the higher strength of the controlled-release range — prescribed for patients requiring stronger serotonergic effect for depression (ذہنی اداسی), anxiety disorders (بے چینی), panic disorder, PTSD, and premenstrual dysphoric disorder (PMDD) — always under close psychiatric or medical supervision.
What is Paraxyl CR 37.5mg Used For?
- Major depressive disorder — treatment of moderate to severe depression and prevention of depressive relapse (ذہنی اداسی اور ڈپریشن)
- Generalised anxiety disorder (GAD) — reducing persistent, excessive worry and physical anxiety symptoms (عمومی بے چینی)
- Panic disorder — treatment of recurrent unexpected panic attacks with or without agoraphobia (گھبراہٹ کے دورے)
- Social anxiety disorder — reducing fear and avoidance in social and performance situations (سماجی بے چینی)
- Post-traumatic stress disorder (PTSD) — managing intrusive memories, hyperarousal, and avoidance following traumatic events (صدمے کے بعد کی ذہنی کیفیت)
- Obsessive-compulsive disorder (OCD) — reducing obsessive thoughts and compulsive behaviours (وسواس)
- Premenstrual dysphoric disorder (PMDD) — managing severe mood, irritability, and physical symptoms in the premenstrual phase
- Menopausal hot flushes — non-hormonal management of vasomotor symptoms in menopausal women under medical supervision
How Does Paraxyl CR 37.5mg Work?
Serotonin Reuptake Inhibition: Nerve cells in the brain communicate by releasing chemical messengers — particularly serotonin — into the synapse (the gap between nerve cells). After transmitting its signal, serotonin is normally reabsorbed back into the releasing nerve cell through a transporter protein called the serotonin reuptake transporter (SERT). In depression and anxiety disorders, serotonin signalling is reduced — leaving insufficient serotonin available in the synapse to adequately regulate mood, emotional responses, and anxiety. Paroxetine selectively blocks the SERT transporter — preventing serotonin reabsorption and allowing it to remain active in the synapse for longer. The resulting increase in synaptic serotonin gradually restores normal mood regulation, reduces anxiety, improves emotional resilience, and stabilises the neurochemical environment that underlies depressive and anxiety disorders.
Paroxetine's Unique Receptor Profile: Paroxetine is the most potent SERT inhibitor among the SSRIs — producing stronger serotonin reuptake blockade at equivalent doses than Fluoxetine, Sertraline, or Citalopram. It also has mild anticholinergic properties and norepinephrine reuptake inhibition at higher doses — contributing to its effectiveness across a broader range of anxiety disorders and making it particularly useful for panic disorder and social anxiety. However these additional receptor effects also contribute to its withdrawal sensitivity — making gradual tapering on discontinuation essential.
Controlled-Release Advantage: The controlled-release formulation of Paraxyl CR releases Paroxetine gradually over 4 to 5 hours — avoiding the sharp peak blood level spike of immediate-release tablets. This reduces the intensity of peak-related side effects — particularly nausea — without compromising overall therapeutic effectiveness. Stable blood levels throughout the day also reduce the risk of between-dose mood fluctuations and the discontinuation sensitivity that Paroxetine is known for.
Dosage and Administration
⚠️ Always take exactly as prescribed by your doctor. Never stop Paraxyl CR suddenly — abrupt discontinuation causes serious withdrawal symptoms. Full antidepressant effect takes 2 to 4 weeks to develop.
| Indication | Usual Starting Dose | Frequency | Usual Maintenance Dose |
|---|---|---|---|
| Major depression | 25mg CR | Once daily | 37.5mg — 62.5mg daily |
| Generalised anxiety disorder | 12.5–25mg CR | Once daily | 37.5mg daily |
| Panic disorder | 12.5mg CR | Once daily | 37.5mg — 62.5mg daily |
| Social anxiety disorder | 12.5–25mg CR | Once daily | 37.5mg daily |
| PTSD | 25mg CR | Once daily | 37.5mg — 62.5mg daily |
| OCD | 25mg CR | Once daily | 37.5mg — 62.5mg daily |
| PMDD | 12.5–25mg CR | Once daily or cyclically | 25mg — 37.5mg daily |
Critical Dosing Rules:
- Full antidepressant and anti-anxiety effect takes 2 to 4 weeks of consistent daily use to develop — never stop because the medicine does not seem to work immediately; premature discontinuation is the most common cause of treatment failure
- Never stop Paraxyl CR suddenly — Paroxetine has the highest discontinuation syndrome risk among all SSRIs; abrupt stopping causes dizziness, electric shock sensations, nausea, irritability, and severe anxiety — always taper very slowly over several weeks under your doctor's direct supervision
- Always start at the lowest effective dose and increase gradually — dose increases should be made no faster than every 1 to 2 weeks under medical supervision
- Elderly patients should start at 12.5mg CR — more sensitive to serotonergic and anticholinergic effects; maximum dose in elderly is generally 37.5mg
- Never crush or chew the controlled-release tablet — this destroys the controlled-release mechanism and releases the full dose immediately, increasing side effects dramatically
How to Take:
- Swallow the tablet whole with a full glass of water — never crush, split, or chew
- Take with food — reduces nausea and improves absorption consistency
- Take in the morning — Paroxetine can cause either sedation or activation; morning dosing is generally preferred to avoid sleep disruption
- Take at the same time each day — consistent daily dosing maintains stable blood levels and reduces discontinuation sensitivity
- If a dose is missed, take it as soon as remembered the same day — skip if it is the next day; never double the dose
Active Ingredients
| Ingredient | Strength per Tablet |
|---|---|
| Paroxetine Hydrochloride (Controlled Release) | 37.5mg |
Who Should NOT Take Paraxyl CR 37.5mg?
Do not take if you:
- Are allergic to Paroxetine or any ingredient in the tablet
- Are currently taking or have taken MAO inhibitors within the last 14 days — risk of life-threatening serotonin syndrome
- Are taking Thioridazine or Pimozide — serious cardiac arrhythmia risk
- Are taking Linezolid or intravenous Methylene Blue — serotonin syndrome risk
- Are under 18 years of age — not approved for depression in children and adolescents; increased suicidal thinking risk
- Are in the manic phase of bipolar disorder
Always consult your doctor before taking Paraxyl CR if you have:
- Bipolar disorder — SSRIs can trigger manic episodes without a mood stabiliser (دو قطبی ذہنی عارضہ)
- Epilepsy or history of seizures (مرگی) — Paroxetine lowers seizure threshold
- Liver disease (جگر کی بیماری) — significantly reduced Paroxetine metabolism; dose reduction required
- Kidney disease (گردے کی بیماری) — monitor and use lower doses
- Bleeding disorders or are taking anticoagulants — SSRIs increase bleeding risk by reducing platelet serotonin
- Heart disease or irregular heartbeat (دل کی بیماری)
- Glaucoma — Paroxetine's mild anticholinergic effect can raise intraocular pressure
- Enlarged prostate or urinary difficulties — anticholinergic effects may worsen urinary retention
- History of suicidal thoughts — close monitoring required particularly in first weeks and after dose changes
- Are pregnant — Paroxetine carries a specific risk of neonatal cardiac defects and neonatal adaptation syndrome; must be discussed with obstetrician
- Are breastfeeding
- Are elderly — start at 12.5mg; higher sensitivity to side effects and falls risk
Side Effects
Common Side Effects:
- Nausea — most common early side effect; significantly reduced by controlled-release formulation and taking with food; usually improves after 1 to 2 weeks
- Headache — usually mild and temporary
- Drowsiness or fatigue — particularly in the first few weeks
- Dry mouth — mild anticholinergic effect of Paroxetine
- Sweating — increased perspiration; common SSRI class effect
- Sexual dysfunction — reduced libido, delayed ejaculation, or difficulty reaching orgasm — common and often persistent; discuss with your doctor
- Weight gain — common with long-term Paroxetine use; more pronounced than with other SSRIs
- Constipation — mild anticholinergic effect
- Dizziness — particularly when standing up quickly
Serious Side Effects — Stop Taking and Seek Medical Help Immediately:
- Serotonin syndrome — agitation, confusion, rapid heartbeat, high fever, severe muscle twitching, rigidity, or loss of coordination — life-threatening emergency particularly if combined with other serotonergic medicines or MAO inhibitors (طبی ہنگامی صورتحال)
- Severe discontinuation syndrome — electric shock-like sensations, severe dizziness, intense anxiety, nausea, and flu-like symptoms — if Paraxyl CR is stopped suddenly; always taper slowly
- Suicidal thoughts or worsening depression — particularly in the first weeks of treatment or after dose changes; antidepressants can increase suicidal ideation in patients under 25 — seek immediate help (فوری طبی مدد حاصل کریں)
- Manic episode — sudden euphoria, racing thoughts, reckless behaviour, significantly reduced need for sleep — in patients with undiagnosed bipolar disorder
- Severe bleeding — unusual bruising, prolonged bleeding, gastrointestinal bleeding — SSRIs reduce platelet aggregation; risk increases significantly with NSAIDs or anticoagulants
- Hyponatraemia (dangerously low sodium) — confusion, headache, weakness, seizures — SSRI-induced syndrome of inappropriate ADH secretion (SIADH); particularly in elderly patients
- Seizures — Paroxetine lowers seizure threshold; any new seizure requires immediate medical evaluation
- Severe allergic reaction — swelling of face, lips, tongue or throat, difficulty breathing, widespread rash (یہ طبی ہنگامی صورتحال ہے)
- Acute angle-closure glaucoma — sudden severe eye pain, blurred vision, halos around lights — stop immediately and seek emergency ophthalmology care
Drug Interactions
| Medicine / Substance | Possible Interaction |
|---|---|
| MAO Inhibitors (e.g., Phenelzine, Tranylcypromine, Linezolid) | Absolutely contraindicated — causes life-threatening serotonin syndrome; stop MAO inhibitors at least 14 days before starting Paroxetine; wait at least 14 days after stopping Paroxetine before starting an MAO inhibitor |
| Thioridazine / Pimozide | Contraindicated — Paroxetine increases blood levels of these antipsychotics causing serious and potentially fatal cardiac arrhythmia |
| Other SSRIs / SNRIs (e.g., Fluoxetine, Venlafaxine) | Increased serotonin syndrome risk — avoid combining serotonergic medicines without strict psychiatric supervision |
| Tramadol / Triptans (e.g., Sumatriptan) | Increased serotonin syndrome risk — use with extreme caution under medical supervision |
| Warfarin / anticoagulants / Clopidogrel | Paroxetine increases bleeding risk through platelet serotonin depletion — monitor INR closely; significant bleeding risk with anticoagulant combination |
| NSAIDs (e.g., Ibuprofen, Diclofenac, Aspirin) | Additive gastrointestinal bleeding risk — combined SSRI and NSAID use significantly increases GI bleed risk; consider adding stomach protection with Omeprazole |
| Tamoxifen (breast cancer treatment) | Paroxetine is a potent CYP2D6 inhibitor — significantly reduces conversion of Tamoxifen to its active form, reducing its cancer-fighting effectiveness; avoid combination wherever possible |
| Tricyclic antidepressants (e.g., Amitriptyline) | Paroxetine dramatically increases TCA blood levels through CYP2D6 inhibition — serious toxicity risk; avoid or use only under strict supervision with very low TCA doses |
| Antipsychotics (e.g., Risperidone, Haloperidol) | Paroxetine increases blood levels of many antipsychotics through CYP2D6 inhibition — toxicity and cardiac arrhythmia risk; monitor closely |
| Metoprolol / other beta-blockers | Paroxetine significantly increases Metoprolol blood levels — serious bradycardia risk; monitor heart rate carefully |
| Antiepileptics (e.g., Carbamazepine, Phenytoin) | Reduce Paroxetine blood levels — may reduce antidepressant effectiveness; Paroxetine also lowers seizure threshold |
| Lithium | Additive serotonergic effects — increased serotonin syndrome risk; monitor lithium levels and neurological status closely |
| Alcohol (شراب) | Enhances CNS depression and sedation — unpredictably worsens depression and anxiety; avoid completely during treatment |
| St John's Wort | Increased serotonin syndrome risk — never combine herbal serotonergic supplements with Paroxetine |
Storage Instructions
- Store below 25°C in a cool, dry place
- Protect from moisture and direct sunlight
- Keep in original blister pack until use — moisture degrades the controlled-release coating
- Keep out of reach of children (بچوں کی پہنچ سے دور رکھیں)
- Do not use after the expiry date printed on the pack
Frequently Asked Questions (FAQs)
Q: Why must Paraxyl CR 37.5mg never be stopped suddenly? Paroxetine has the highest discontinuation syndrome risk among all SSRIs — stopping suddenly causes severe electric shock-like sensations, intense dizziness, nausea, and anxiety; always taper the dose very slowly over several weeks under your doctor's direct supervision.
Q: How long does Paraxyl CR 37.5mg take to work? Full antidepressant and anti-anxiety effect builds gradually over 2 to 4 weeks of consistent daily use — some patients notice improved sleep and energy sooner; never stop because it does not seem to work immediately as premature discontinuation is the most common cause of treatment failure.
Q: Why should Paraxyl CR not be taken with Tamoxifen for breast cancer? Paroxetine is a potent inhibitor of the CYP2D6 enzyme that converts Tamoxifen into its active cancer-fighting form — significantly reducing its effectiveness; a different antidepressant with less CYP2D6 inhibition such as Venlafaxine or Citalopram is strongly preferred in breast cancer patients.
Q: Is Paraxyl CR 37.5mg safe during pregnancy? Paroxetine carries specific pregnancy risks including neonatal cardiac defects and neonatal adaptation syndrome — always discuss the risk-benefit balance with your obstetrician and psychiatrist before taking or continuing Paroxetine during pregnancy; never stop without medical advice as untreated depression also carries serious risks.
Medical Disclaimer: This information is for general awareness only and does not replace advice from your doctor or pharmacist. Paraxyl CR 37.5mg is a prescription psychiatric medicine — never start, stop, or adjust the dose without consulting your healthcare provider. If you or someone you know is experiencing thoughts of self-harm or suicide, please seek immediate medical help or contact a mental health professional.